期刊文献+

Hepatocellular carcinoma in Budd-Chiari syndrome:A single center experience with long-term follow-up in South Korea 被引量:13

Hepatocellular carcinoma in Budd-Chiari syndrome:A single center experience with long-term follow-up in South Korea
下载PDF
导出
摘要 AIM:To evaluate long-term clinical course of BuddChiari syndrome(BCS) and predictive factors associated with the development of hepatocellular carcinoma(HCC) and survival.METHODS:We analyzed 67 patients with BCS between June 1988 and May 2008.The diagnosis of BCS was confirmed by hepatic venous outflow obstruction shown on abdominal ultrasound sonography,computed tomography,magnetic resonance imaging,or venography.The median follow-up period was 103 ± 156 [interquartile range(IQR)] mo.RESULTS:The median age of the patients was 47 ± 16(IQR) years.At diagnosis,54 patients had cirrhosis,25(37.3%) Child-Pugh class A,23(34.3%) Child-Pugh class B,and six(9.0%) patients Child-Pugh class C.During the follow-up period,HCC was developed in 17 patients,and the annual incidence of HCC in patients with BCS was 2.8%.Patients in HCC group(n = 17) had higher hepatic venous pressure gradient(HVPG) than those in non-HCC group(n = 50)(21 ± 12 mmHg vs 14 ± 7 mmHg,P = 0.019).The survival rate of BCS patients was 86.2% for 5 years,73.8% for 10 years,and 61.2% for 15 years.In patients with BCS and HCC,survival was 79% for 5 years,43.1% for 10 years,and 21.5% for 15 years.CONCLUSION:The incidence of HCC in patients with BCS was similar to that in patients with other etiologic cirrhosis in South Korea.The HVPG is expected to provide additional information for predicting HCC development in BCS patients. AIM:To evaluate long-term clinical course of BuddChiari syndrome(BCS) and predictive factors associated with the development of hepatocellular carcinoma(HCC) and survival.METHODS:We analyzed 67 patients with BCS between June 1988 and May 2008.The diagnosis of BCS was confirmed by hepatic venous outflow obstruction shown on abdominal ultrasound sonography,computed tomography,magnetic resonance imaging,or venography.The median follow-up period was 103 ± 156 [interquartile range(IQR)] mo.RESULTS:The median age of the patients was 47 ± 16(IQR) years.At diagnosis,54 patients had cirrhosis,25(37.3%) Child-Pugh class A,23(34.3%) Child-Pugh class B,and six(9.0%) patients Child-Pugh class C.During the follow-up period,HCC was developed in 17 patients,and the annual incidence of HCC in patients with BCS was 2.8%.Patients in HCC group(n = 17) had higher hepatic venous pressure gradient(HVPG) than those in non-HCC group(n = 50)(21 ± 12 mmHg vs 14 ± 7 mmHg,P = 0.019).The survival rate of BCS patients was 86.2% for 5 years,73.8% for 10 years,and 61.2% for 15 years.In patients with BCS and HCC,survival was 79% for 5 years,43.1% for 10 years,and 21.5% for 15 years.CONCLUSION:The incidence of HCC in patients with BCS was similar to that in patients with other etiologic cirrhosis in South Korea.The HVPG is expected to provide additional information for predicting HCC development in BCS patients.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第16期1946-1952,共7页 世界胃肠病学杂志(英文版)
基金 Supported by A grant of the South Korea Healthcare Technology R and D Project,Ministry of Health and Welfare,South Korea,No.A102065
关键词 综合征 肝癌 随访 韩国 BCS 毫米汞柱 磁共振成像 肝细胞癌 Budd-Chiari syndrome Hepatocellular carcinoma Prognosis
  • 相关文献

参考文献24

  • 1Dhiman RK,Saraswat VA,Radhakrishnan S,Parashar A, Agarwal DK,Naik SR. Multiple venous thromboses and membranous obstruction of inferior vena cava in association with hereditary protein C deficiency: a case report. J Gastro- enterol Hepatol 1992; 7: 434-438.
  • 2Nakashima T,Okuda K,Kojiro M,Jimi A,Yamaguchi R, Sakamoto K,Ikari T. Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years. Can- cer 1983; 51: 863-877.
  • 3Matsui S,Ichida T,Watanabe M,Sugitani S,Suda T,Taka- hashi T,Asakura H. Clinical features and etiology of hepa- tocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection. J Gastroenterol Hepatol 2000; 15: 1205-1211.
  • 4Tanaka M,Wanless IR. Pathology of the liver in Budd-Chi- ari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis,veno-portal cirrhosis,and large regen- erative nodules. Hepatology 1998; 27: 488-496.
  • 5Okuda K. Inferior vena cava thrombosis at its hepatic por- tion (obliterative hepatocavopathy). Semin Liver Dis 2002; 22: 15-26.
  • 6Gwon D,Ko GY,Yoon HK,Sung KB,Kim JH,Lee SS,Lee JM,Ohm JY,Shin JH,Song HY. Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence,characteristics,and risk factors and clinical efficacy of TACE. Radiology 2010; 254: 617-626.
  • 7Moucari R,Rautou PE,Cazals-Hatem D,Geara A,Bureau C, Consigny Y,Francoz C,Denninger MH,Vilgrain V,Belghiti J,Durand F,Valla D,Plessier A. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut 2008; 57: 828-835.
  • 8Eapen CE,Mammen T,Moses V,Shyamkumar NK. Chang- ing profile of Budd Chiari syndrome in India. Indian J Gastro- enterol 2007; 26: 77-81.
  • 9Kew MC,McKnight A,Hodkinson J,Bukofzer S,Esser JD. The role of membranous obstruction of the inferior vena cava in the etiology of hepatocellular carcinoma in Southern African blacks. Hepatology 1989; 9: 121-125.
  • 10Rector WG,Xu YH,Goldstein L,Peters RL,Reynolds TB. Membranous obstruction of the inferior vena cava in the United States. Medicine (Baltimore) 1985; 64: 134-143.

同被引文献89

引证文献13

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部